Product
NBL-020
Aliases
NBL-020 for Injection
1 clinical trial
1 indication
Indication
Advanced Malignant TumorsClinical trial
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Anti-tumor Activity of NBL-020 Injection in Subjects With Advanced Malignant Tumors.Status: Recruiting, Estimated PCD: 2025-08-01